Site for Multicenter Randomized Pragmatic Clinical Trial Comparing Two- Versus Three-Antibiotic Therapy for Pulmonary Mycobacterium avium Complex Disease

Brief description of study

Site for To determine whether 2-drug is non-inferior to 3-drug (standard) therapy against pulmonary Mycobacterium avium complex (MAC) and whether 2-drug therapy is better tolerated than 3-drug therapy.


Clinical Study Identifier: s19-00328
ClinicalTrials.gov Identifier: NCT03672630
Principal Investigator: Doreen J Addrizzo-Harris.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.